Filing Details
- Accession Number:
- 0001127602-13-033424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-03 16:07:33
- Reporting Period:
- 2013-12-02
- Filing Date:
- 2013-12-03
- Accepted Time:
- 2013-12-03 16:07:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1210238 | Kenneth Bate | 65 Hayden Avenue Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-02 | 12,500 | $10.09 | 20,414 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-02 | 10,294 | $67.53 | 10,120 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-02 | 2,206 | $68.10 | 7,914 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-12-02 | 12,500 | $0.00 | 12,500 | $10.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-06-10 | 2014-06-10 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a Rule 10(b)5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $66.9400 to $67.9400. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $67.9500 to $68.2900. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 100% on one-year anniversary of grant.